nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafcillin—CYP1A2—Erlotinib—lung cancer	0.0604	0.105	CbGbCtD
Nafcillin—CYP3A4—Topotecan—lung cancer	0.0585	0.102	CbGbCtD
Nafcillin—SLC22A6—Methotrexate—lung cancer	0.0566	0.0989	CbGbCtD
Nafcillin—CYP3A4—Gefitinib—lung cancer	0.0535	0.0934	CbGbCtD
Nafcillin—CYP3A4—Teniposide—lung cancer	0.0519	0.0906	CbGbCtD
Nafcillin—CYP1A2—Etoposide—lung cancer	0.0437	0.0763	CbGbCtD
Nafcillin—CYP3A4—Vinorelbine—lung cancer	0.0412	0.072	CbGbCtD
Nafcillin—CYP3A4—Crizotinib—lung cancer	0.0328	0.0573	CbGbCtD
Nafcillin—CYP3A4—Erlotinib—lung cancer	0.0316	0.0552	CbGbCtD
Nafcillin—CYP3A4—Paclitaxel—lung cancer	0.029	0.0506	CbGbCtD
Nafcillin—CYP3A4—Irinotecan—lung cancer	0.0286	0.0499	CbGbCtD
Nafcillin—CYP3A4—Vinblastine—lung cancer	0.0254	0.0444	CbGbCtD
Nafcillin—CYP3A4—Etoposide—lung cancer	0.0229	0.04	CbGbCtD
Nafcillin—CYP3A4—Docetaxel—lung cancer	0.0209	0.0366	CbGbCtD
Nafcillin—CYP3A4—Doxorubicin—lung cancer	0.0156	0.0273	CbGbCtD
Nafcillin—Arthralgia—Vinorelbine—lung cancer	0.000588	0.00167	CcSEcCtD
Nafcillin—Renal failure—Paclitaxel—lung cancer	0.000585	0.00166	CcSEcCtD
Nafcillin—Discomfort—Vinorelbine—lung cancer	0.000581	0.00165	CcSEcCtD
Nafcillin—Pain—Vinblastine—lung cancer	0.00058	0.00164	CcSEcCtD
Nafcillin—Inflammation—Doxorubicin—lung cancer	0.00058	0.00164	CcSEcCtD
Nafcillin—Stomatitis—Paclitaxel—lung cancer	0.00058	0.00164	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Topotecan—lung cancer	0.000569	0.00161	CcSEcCtD
Nafcillin—Haematuria—Paclitaxel—lung cancer	0.000567	0.00161	CcSEcCtD
Nafcillin—Agranulocytosis—Etoposide—lung cancer	0.000566	0.0016	CcSEcCtD
Nafcillin—Vomiting—Teniposide—lung cancer	0.000566	0.0016	CcSEcCtD
Nafcillin—Anaphylactic shock—Vinorelbine—lung cancer	0.000564	0.0016	CcSEcCtD
Nafcillin—Pain—Topotecan—lung cancer	0.000564	0.0016	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Erlotinib—lung cancer	0.000563	0.0016	CcSEcCtD
Nafcillin—Rash—Teniposide—lung cancer	0.000561	0.00159	CcSEcCtD
Nafcillin—Dermatitis—Teniposide—lung cancer	0.00056	0.00159	CcSEcCtD
Nafcillin—Feeling abnormal—Vinblastine—lung cancer	0.000559	0.00158	CcSEcCtD
Nafcillin—Pain—Erlotinib—lung cancer	0.000558	0.00158	CcSEcCtD
Nafcillin—Bronchospasm—Docetaxel—lung cancer	0.000556	0.00158	CcSEcCtD
Nafcillin—Gastrointestinal pain—Vinblastine—lung cancer	0.000555	0.00157	CcSEcCtD
Nafcillin—Thrombophlebitis—Methotrexate—lung cancer	0.000545	0.00154	CcSEcCtD
Nafcillin—Feeling abnormal—Topotecan—lung cancer	0.000543	0.00154	CcSEcCtD
Nafcillin—Gastrointestinal pain—Topotecan—lung cancer	0.000539	0.00153	CcSEcCtD
Nafcillin—Skin exfoliation—Doxorubicin—lung cancer	0.000537	0.00152	CcSEcCtD
Nafcillin—Pancytopenia—Docetaxel—lung cancer	0.000537	0.00152	CcSEcCtD
Nafcillin—Abdominal pain—Vinblastine—lung cancer	0.000536	0.00152	CcSEcCtD
Nafcillin—Gastrointestinal pain—Erlotinib—lung cancer	0.000533	0.00151	CcSEcCtD
Nafcillin—Ill-defined disorder—Irinotecan—lung cancer	0.000529	0.0015	CcSEcCtD
Nafcillin—Neutropenia—Docetaxel—lung cancer	0.000529	0.0015	CcSEcCtD
Nafcillin—Nausea—Teniposide—lung cancer	0.000528	0.0015	CcSEcCtD
Nafcillin—Hypotension—Vinorelbine—lung cancer	0.000527	0.00149	CcSEcCtD
Nafcillin—Urticaria—Topotecan—lung cancer	0.000524	0.00148	CcSEcCtD
Nafcillin—Abdominal pain—Topotecan—lung cancer	0.000521	0.00148	CcSEcCtD
Nafcillin—Body temperature increased—Topotecan—lung cancer	0.000521	0.00148	CcSEcCtD
Nafcillin—Abdominal pain—Erlotinib—lung cancer	0.000516	0.00146	CcSEcCtD
Nafcillin—Body temperature increased—Erlotinib—lung cancer	0.000516	0.00146	CcSEcCtD
Nafcillin—Ill-defined disorder—Gemcitabine—lung cancer	0.000515	0.00146	CcSEcCtD
Nafcillin—Malaise—Irinotecan—lung cancer	0.000514	0.00146	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000514	0.00146	CcSEcCtD
Nafcillin—Malaise—Gemcitabine—lung cancer	0.000501	0.00142	CcSEcCtD
Nafcillin—Hypersensitivity—Vinblastine—lung cancer	0.0005	0.00142	CcSEcCtD
Nafcillin—Renal failure—Docetaxel—lung cancer	0.000496	0.0014	CcSEcCtD
Nafcillin—Stomatitis—Docetaxel—lung cancer	0.000491	0.00139	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000487	0.00138	CcSEcCtD
Nafcillin—Hypersensitivity—Topotecan—lung cancer	0.000486	0.00138	CcSEcCtD
Nafcillin—Pain—Vinorelbine—lung cancer	0.000482	0.00137	CcSEcCtD
Nafcillin—Ill-defined disorder—Cisplatin—lung cancer	0.00048	0.00136	CcSEcCtD
Nafcillin—Discomfort—Irinotecan—lung cancer	0.000479	0.00136	CcSEcCtD
Nafcillin—Phlebitis—Doxorubicin—lung cancer	0.000474	0.00134	CcSEcCtD
Nafcillin—Arthralgia—Gemcitabine—lung cancer	0.000473	0.00134	CcSEcCtD
Nafcillin—Myalgia—Gemcitabine—lung cancer	0.000473	0.00134	CcSEcCtD
Nafcillin—Thrombophlebitis—Doxorubicin—lung cancer	0.000472	0.00134	CcSEcCtD
Nafcillin—Agranulocytosis—Docetaxel—lung cancer	0.00047	0.00133	CcSEcCtD
Nafcillin—Discomfort—Gemcitabine—lung cancer	0.000467	0.00132	CcSEcCtD
Nafcillin—Malaise—Cisplatin—lung cancer	0.000467	0.00132	CcSEcCtD
Nafcillin—Pruritus—Topotecan—lung cancer	0.000466	0.00132	CcSEcCtD
Nafcillin—Anaphylactic shock—Irinotecan—lung cancer	0.000465	0.00132	CcSEcCtD
Nafcillin—Feeling abnormal—Vinorelbine—lung cancer	0.000465	0.00132	CcSEcCtD
Nafcillin—Diarrhoea—Vinblastine—lung cancer	0.000464	0.00132	CcSEcCtD
Nafcillin—Pruritus—Erlotinib—lung cancer	0.000461	0.00131	CcSEcCtD
Nafcillin—Gastrointestinal pain—Vinorelbine—lung cancer	0.000461	0.00131	CcSEcCtD
Nafcillin—Shock—Irinotecan—lung cancer	0.000458	0.0013	CcSEcCtD
Nafcillin—Anaphylactic shock—Gemcitabine—lung cancer	0.000453	0.00128	CcSEcCtD
Nafcillin—Diarrhoea—Topotecan—lung cancer	0.000451	0.00128	CcSEcCtD
Nafcillin—Urticaria—Vinorelbine—lung cancer	0.000448	0.00127	CcSEcCtD
Nafcillin—Diarrhoea—Erlotinib—lung cancer	0.000446	0.00126	CcSEcCtD
Nafcillin—Body temperature increased—Vinorelbine—lung cancer	0.000446	0.00126	CcSEcCtD
Nafcillin—Abdominal pain—Vinorelbine—lung cancer	0.000446	0.00126	CcSEcCtD
Nafcillin—Myalgia—Cisplatin—lung cancer	0.000441	0.00125	CcSEcCtD
Nafcillin—Ill-defined disorder—Etoposide—lung cancer	0.00044	0.00125	CcSEcCtD
Nafcillin—Liver function test abnormal—Methotrexate—lung cancer	0.000435	0.00123	CcSEcCtD
Nafcillin—Discomfort—Cisplatin—lung cancer	0.000435	0.00123	CcSEcCtD
Nafcillin—Hypotension—Irinotecan—lung cancer	0.000435	0.00123	CcSEcCtD
Nafcillin—Vomiting—Vinblastine—lung cancer	0.000432	0.00122	CcSEcCtD
Nafcillin—Ill-defined disorder—Paclitaxel—lung cancer	0.000431	0.00122	CcSEcCtD
Nafcillin—Renal impairment—Doxorubicin—lung cancer	0.000429	0.00122	CcSEcCtD
Nafcillin—Malaise—Etoposide—lung cancer	0.000428	0.00121	CcSEcCtD
Nafcillin—Angioedema—Paclitaxel—lung cancer	0.000425	0.0012	CcSEcCtD
Nafcillin—Hypotension—Gemcitabine—lung cancer	0.000423	0.0012	CcSEcCtD
Nafcillin—Anaphylactic shock—Cisplatin—lung cancer	0.000422	0.0012	CcSEcCtD
Nafcillin—Vomiting—Topotecan—lung cancer	0.000419	0.00119	CcSEcCtD
Nafcillin—Malaise—Paclitaxel—lung cancer	0.000419	0.00119	CcSEcCtD
Nafcillin—Rash—Topotecan—lung cancer	0.000416	0.00118	CcSEcCtD
Nafcillin—Hypersensitivity—Vinorelbine—lung cancer	0.000416	0.00118	CcSEcCtD
Nafcillin—Dermatitis—Topotecan—lung cancer	0.000415	0.00118	CcSEcCtD
Nafcillin—Vomiting—Erlotinib—lung cancer	0.000415	0.00117	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000413	0.00117	CcSEcCtD
Nafcillin—Rash—Erlotinib—lung cancer	0.000411	0.00117	CcSEcCtD
Nafcillin—Dermatitis—Erlotinib—lung cancer	0.000411	0.00116	CcSEcCtD
Nafcillin—Eosinophilia—Methotrexate—lung cancer	0.000403	0.00114	CcSEcCtD
Nafcillin—Nausea—Vinblastine—lung cancer	0.000403	0.00114	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Irinotecan—lung cancer	0.000402	0.00114	CcSEcCtD
Nafcillin—Pruritus—Vinorelbine—lung cancer	0.000399	0.00113	CcSEcCtD
Nafcillin—Discomfort—Etoposide—lung cancer	0.000399	0.00113	CcSEcCtD
Nafcillin—Pain—Irinotecan—lung cancer	0.000398	0.00113	CcSEcCtD
Nafcillin—Arthralgia—Paclitaxel—lung cancer	0.000396	0.00112	CcSEcCtD
Nafcillin—Myalgia—Paclitaxel—lung cancer	0.000396	0.00112	CcSEcCtD
Nafcillin—Hypotension—Cisplatin—lung cancer	0.000395	0.00112	CcSEcCtD
Nafcillin—Nausea—Topotecan—lung cancer	0.000392	0.00111	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000391	0.00111	CcSEcCtD
Nafcillin—Discomfort—Paclitaxel—lung cancer	0.000391	0.00111	CcSEcCtD
Nafcillin—Abdominal discomfort—Methotrexate—lung cancer	0.000391	0.00111	CcSEcCtD
Nafcillin—Pain—Gemcitabine—lung cancer	0.000387	0.0011	CcSEcCtD
Nafcillin—Nausea—Erlotinib—lung cancer	0.000387	0.0011	CcSEcCtD
Nafcillin—Pancytopenia—Methotrexate—lung cancer	0.000387	0.0011	CcSEcCtD
Nafcillin—Anaphylactic shock—Etoposide—lung cancer	0.000387	0.0011	CcSEcCtD
Nafcillin—Diarrhoea—Vinorelbine—lung cancer	0.000386	0.00109	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000385	0.00109	CcSEcCtD
Nafcillin—Feeling abnormal—Irinotecan—lung cancer	0.000383	0.00109	CcSEcCtD
Nafcillin—Neutropenia—Methotrexate—lung cancer	0.000381	0.00108	CcSEcCtD
Nafcillin—Gastrointestinal pain—Irinotecan—lung cancer	0.00038	0.00108	CcSEcCtD
Nafcillin—Anaphylactic shock—Paclitaxel—lung cancer	0.000379	0.00107	CcSEcCtD
Nafcillin—Liver function test abnormal—Doxorubicin—lung cancer	0.000377	0.00107	CcSEcCtD
Nafcillin—Feeling abnormal—Gemcitabine—lung cancer	0.000373	0.00106	CcSEcCtD
Nafcillin—Shock—Paclitaxel—lung cancer	0.000373	0.00106	CcSEcCtD
Nafcillin—Body temperature increased—Irinotecan—lung cancer	0.000368	0.00104	CcSEcCtD
Nafcillin—Abdominal pain—Irinotecan—lung cancer	0.000368	0.00104	CcSEcCtD
Nafcillin—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000368	0.00104	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Cisplatin—lung cancer	0.000365	0.00103	CcSEcCtD
Nafcillin—Hypotension—Etoposide—lung cancer	0.000362	0.00102	CcSEcCtD
Nafcillin—Pain—Cisplatin—lung cancer	0.000361	0.00102	CcSEcCtD
Nafcillin—Vomiting—Vinorelbine—lung cancer	0.000359	0.00102	CcSEcCtD
Nafcillin—Body temperature increased—Gemcitabine—lung cancer	0.000358	0.00101	CcSEcCtD
Nafcillin—Renal failure—Methotrexate—lung cancer	0.000357	0.00101	CcSEcCtD
Nafcillin—Rash—Vinorelbine—lung cancer	0.000356	0.00101	CcSEcCtD
Nafcillin—Dermatitis—Vinorelbine—lung cancer	0.000355	0.00101	CcSEcCtD
Nafcillin—Hypotension—Paclitaxel—lung cancer	0.000354	0.001	CcSEcCtD
Nafcillin—Stomatitis—Methotrexate—lung cancer	0.000354	0.001	CcSEcCtD
Nafcillin—Eosinophilia—Doxorubicin—lung cancer	0.000349	0.00099	CcSEcCtD
Nafcillin—Feeling abnormal—Cisplatin—lung cancer	0.000348	0.000986	CcSEcCtD
Nafcillin—Haematuria—Methotrexate—lung cancer	0.000346	0.000981	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000346	0.000979	CcSEcCtD
Nafcillin—Hypersensitivity—Irinotecan—lung cancer	0.000343	0.000971	CcSEcCtD
Nafcillin—Agranulocytosis—Methotrexate—lung cancer	0.000339	0.000961	CcSEcCtD
Nafcillin—Arthralgia—Docetaxel—lung cancer	0.000335	0.00095	CcSEcCtD
Nafcillin—Myalgia—Docetaxel—lung cancer	0.000335	0.00095	CcSEcCtD
Nafcillin—Pancytopenia—Doxorubicin—lung cancer	0.000335	0.000949	CcSEcCtD
Nafcillin—Nausea—Vinorelbine—lung cancer	0.000335	0.000949	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Etoposide—lung cancer	0.000334	0.000946	CcSEcCtD
Nafcillin—Body temperature increased—Cisplatin—lung cancer	0.000334	0.000946	CcSEcCtD
Nafcillin—Pain—Etoposide—lung cancer	0.000331	0.000937	CcSEcCtD
Nafcillin—Neutropenia—Doxorubicin—lung cancer	0.00033	0.000935	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000328	0.000928	CcSEcCtD
Nafcillin—Pain—Paclitaxel—lung cancer	0.000324	0.000919	CcSEcCtD
Nafcillin—Anaphylactic shock—Docetaxel—lung cancer	0.000322	0.000911	CcSEcCtD
Nafcillin—Pruritus—Gemcitabine—lung cancer	0.000321	0.000908	CcSEcCtD
Nafcillin—Feeling abnormal—Etoposide—lung cancer	0.000319	0.000903	CcSEcCtD
Nafcillin—Diarrhoea—Irinotecan—lung cancer	0.000318	0.000901	CcSEcCtD
Nafcillin—Gastrointestinal pain—Etoposide—lung cancer	0.000316	0.000896	CcSEcCtD
Nafcillin—Shock—Docetaxel—lung cancer	0.000316	0.000896	CcSEcCtD
Nafcillin—Feeling abnormal—Paclitaxel—lung cancer	0.000313	0.000885	CcSEcCtD
Nafcillin—Hypersensitivity—Cisplatin—lung cancer	0.000311	0.000881	CcSEcCtD
Nafcillin—Gastrointestinal pain—Paclitaxel—lung cancer	0.00031	0.000879	CcSEcCtD
Nafcillin—Diarrhoea—Gemcitabine—lung cancer	0.00031	0.000878	CcSEcCtD
Nafcillin—Renal failure—Doxorubicin—lung cancer	0.000309	0.000876	CcSEcCtD
Nafcillin—Urticaria—Etoposide—lung cancer	0.000307	0.000871	CcSEcCtD
Nafcillin—Stomatitis—Doxorubicin—lung cancer	0.000307	0.000869	CcSEcCtD
Nafcillin—Abdominal pain—Etoposide—lung cancer	0.000306	0.000866	CcSEcCtD
Nafcillin—Body temperature increased—Etoposide—lung cancer	0.000306	0.000866	CcSEcCtD
Nafcillin—Urticaria—Paclitaxel—lung cancer	0.000301	0.000854	CcSEcCtD
Nafcillin—Hypotension—Docetaxel—lung cancer	0.0003	0.000851	CcSEcCtD
Nafcillin—Haematuria—Doxorubicin—lung cancer	0.0003	0.00085	CcSEcCtD
Nafcillin—Body temperature increased—Paclitaxel—lung cancer	0.0003	0.000849	CcSEcCtD
Nafcillin—Abdominal pain—Paclitaxel—lung cancer	0.0003	0.000849	CcSEcCtD
Nafcillin—Vomiting—Irinotecan—lung cancer	0.000296	0.000838	CcSEcCtD
Nafcillin—Agranulocytosis—Doxorubicin—lung cancer	0.000294	0.000832	CcSEcCtD
Nafcillin—Rash—Irinotecan—lung cancer	0.000293	0.000831	CcSEcCtD
Nafcillin—Dermatitis—Irinotecan—lung cancer	0.000293	0.00083	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000293	0.00083	CcSEcCtD
Nafcillin—Diarrhoea—Cisplatin—lung cancer	0.000289	0.000818	CcSEcCtD
Nafcillin—Vomiting—Gemcitabine—lung cancer	0.000288	0.000816	CcSEcCtD
Nafcillin—Rash—Gemcitabine—lung cancer	0.000286	0.000809	CcSEcCtD
Nafcillin—Dermatitis—Gemcitabine—lung cancer	0.000285	0.000808	CcSEcCtD
Nafcillin—Hypersensitivity—Etoposide—lung cancer	0.000285	0.000807	CcSEcCtD
Nafcillin—Hypersensitivity—Paclitaxel—lung cancer	0.000279	0.000792	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Docetaxel—lung cancer	0.000278	0.000786	CcSEcCtD
Nafcillin—Nausea—Irinotecan—lung cancer	0.000276	0.000783	CcSEcCtD
Nafcillin—Pain—Docetaxel—lung cancer	0.000275	0.000779	CcSEcCtD
Nafcillin—Pruritus—Etoposide—lung cancer	0.000274	0.000775	CcSEcCtD
Nafcillin—Nausea—Gemcitabine—lung cancer	0.000269	0.000762	CcSEcCtD
Nafcillin—Vomiting—Cisplatin—lung cancer	0.000269	0.000761	CcSEcCtD
Nafcillin—Pruritus—Paclitaxel—lung cancer	0.000268	0.00076	CcSEcCtD
Nafcillin—Rash—Cisplatin—lung cancer	0.000266	0.000754	CcSEcCtD
Nafcillin—Dermatitis—Cisplatin—lung cancer	0.000266	0.000754	CcSEcCtD
Nafcillin—Feeling abnormal—Docetaxel—lung cancer	0.000265	0.000751	CcSEcCtD
Nafcillin—Diarrhoea—Etoposide—lung cancer	0.000265	0.00075	CcSEcCtD
Nafcillin—Ill-defined disorder—Methotrexate—lung cancer	0.000263	0.000746	CcSEcCtD
Nafcillin—Gastrointestinal pain—Docetaxel—lung cancer	0.000263	0.000745	CcSEcCtD
Nafcillin—Diarrhoea—Paclitaxel—lung cancer	0.00026	0.000735	CcSEcCtD
Nafcillin—Malaise—Methotrexate—lung cancer	0.000256	0.000725	CcSEcCtD
Nafcillin—Body temperature increased—Docetaxel—lung cancer	0.000254	0.00072	CcSEcCtD
Nafcillin—Abdominal pain—Docetaxel—lung cancer	0.000254	0.00072	CcSEcCtD
Nafcillin—Nausea—Cisplatin—lung cancer	0.000251	0.000711	CcSEcCtD
Nafcillin—Vomiting—Etoposide—lung cancer	0.000246	0.000697	CcSEcCtD
Nafcillin—Rash—Etoposide—lung cancer	0.000244	0.000691	CcSEcCtD
Nafcillin—Dermatitis—Etoposide—lung cancer	0.000244	0.00069	CcSEcCtD
Nafcillin—Arthralgia—Methotrexate—lung cancer	0.000242	0.000685	CcSEcCtD
Nafcillin—Myalgia—Methotrexate—lung cancer	0.000242	0.000685	CcSEcCtD
Nafcillin—Vomiting—Paclitaxel—lung cancer	0.000241	0.000683	CcSEcCtD
Nafcillin—Rash—Paclitaxel—lung cancer	0.000239	0.000678	CcSEcCtD
Nafcillin—Dermatitis—Paclitaxel—lung cancer	0.000239	0.000677	CcSEcCtD
Nafcillin—Discomfort—Methotrexate—lung cancer	0.000239	0.000677	CcSEcCtD
Nafcillin—Hypersensitivity—Docetaxel—lung cancer	0.000237	0.000671	CcSEcCtD
Nafcillin—Anaphylactic shock—Methotrexate—lung cancer	0.000232	0.000656	CcSEcCtD
Nafcillin—Nausea—Etoposide—lung cancer	0.00023	0.000651	CcSEcCtD
Nafcillin—Ill-defined disorder—Doxorubicin—lung cancer	0.000228	0.000646	CcSEcCtD
Nafcillin—Pruritus—Docetaxel—lung cancer	0.000227	0.000644	CcSEcCtD
Nafcillin—Nausea—Paclitaxel—lung cancer	0.000225	0.000638	CcSEcCtD
Nafcillin—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000224	0.00302	CbGpPWpGaD
Nafcillin—Malaise—Doxorubicin—lung cancer	0.000222	0.000628	CcSEcCtD
Nafcillin—Diarrhoea—Docetaxel—lung cancer	0.00022	0.000623	CcSEcCtD
Nafcillin—CYP1A2—Biological oxidations—GSTM2—lung cancer	0.000219	0.00295	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—CNDP2—lung cancer	0.000219	0.00295	CbGpPWpGaD
Nafcillin—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	0.000217	0.00292	CbGpPWpGaD
Nafcillin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000217	0.00291	CbGpPWpGaD
Nafcillin—Hypotension—Methotrexate—lung cancer	0.000217	0.000613	CcSEcCtD
Nafcillin—CYP1A2—Metapathway biotransformation—GSTM2—lung cancer	0.000216	0.00291	CbGpPWpGaD
Nafcillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000216	0.0029	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—lung cancer	0.000214	0.00288	CbGpPWpGaD
Nafcillin—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000211	0.000598	CcSEcCtD
Nafcillin—Arthralgia—Doxorubicin—lung cancer	0.000209	0.000593	CcSEcCtD
Nafcillin—Myalgia—Doxorubicin—lung cancer	0.000209	0.000593	CcSEcCtD
Nafcillin—Discomfort—Doxorubicin—lung cancer	0.000207	0.000586	CcSEcCtD
Nafcillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000206	0.00277	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—HPGDS—lung cancer	0.000205	0.00276	CbGpPWpGaD
Nafcillin—Vomiting—Docetaxel—lung cancer	0.000204	0.000579	CcSEcCtD
Nafcillin—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000203	0.00274	CbGpPWpGaD
Nafcillin—Rash—Docetaxel—lung cancer	0.000203	0.000574	CcSEcCtD
Nafcillin—Dermatitis—Docetaxel—lung cancer	0.000203	0.000574	CcSEcCtD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—lung cancer	0.000202	0.00272	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—lung cancer	0.000202	0.00272	CbGpPWpGaD
Nafcillin—CYP1A2—Tryptophan metabolism—CYP1A1—lung cancer	0.000202	0.00272	CbGpPWpGaD
Nafcillin—Anaphylactic shock—Doxorubicin—lung cancer	0.000201	0.000568	CcSEcCtD
Nafcillin—Gastrointestinal disorder—Methotrexate—lung cancer	0.0002	0.000567	CcSEcCtD
Nafcillin—CYP1A2—Phase II conjugation—GSTT1—lung cancer	0.000199	0.00268	CbGpPWpGaD
Nafcillin—Pain—Methotrexate—lung cancer	0.000198	0.000561	CcSEcCtD
Nafcillin—CYP1A2—Biological oxidations—CYP2A7—lung cancer	0.000198	0.00267	CbGpPWpGaD
Nafcillin—Shock—Doxorubicin—lung cancer	0.000197	0.000559	CcSEcCtD
Nafcillin—CYP1A2—Phase II conjugation—GCLC—lung cancer	0.000197	0.00265	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—CYP2A7—lung cancer	0.000195	0.00263	CbGpPWpGaD
Nafcillin—Nausea—Docetaxel—lung cancer	0.000191	0.000541	CcSEcCtD
Nafcillin—Feeling abnormal—Methotrexate—lung cancer	0.000191	0.000541	CcSEcCtD
Nafcillin—Gastrointestinal pain—Methotrexate—lung cancer	0.00019	0.000537	CcSEcCtD
Nafcillin—CYP1A2—Arachidonic acid metabolism—CYP1A1—lung cancer	0.000189	0.00254	CbGpPWpGaD
Nafcillin—Hypotension—Doxorubicin—lung cancer	0.000188	0.000531	CcSEcCtD
Nafcillin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000184	0.00248	CbGpPWpGaD
Nafcillin—Urticaria—Methotrexate—lung cancer	0.000184	0.000521	CcSEcCtD
Nafcillin—Abdominal pain—Methotrexate—lung cancer	0.000183	0.000519	CcSEcCtD
Nafcillin—Body temperature increased—Methotrexate—lung cancer	0.000183	0.000519	CcSEcCtD
Nafcillin—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000183	0.000518	CcSEcCtD
Nafcillin—CYP1A2—Biological oxidations—GSTA3—lung cancer	0.000177	0.00238	CbGpPWpGaD
Nafcillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000175	0.00236	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—GSTA3—lung cancer	0.000174	0.00234	CbGpPWpGaD
Nafcillin—CYP3A4—Tryptophan metabolism—CAT—lung cancer	0.000174	0.00234	CbGpPWpGaD
Nafcillin—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000173	0.000491	CcSEcCtD
Nafcillin—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000173	0.00233	CbGpPWpGaD
Nafcillin—Pain—Doxorubicin—lung cancer	0.000172	0.000486	CcSEcCtD
Nafcillin—Hypersensitivity—Methotrexate—lung cancer	0.000171	0.000484	CcSEcCtD
Nafcillin—CYP3A4—Biological oxidations—GSTM2—lung cancer	0.000169	0.00227	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—CNDP2—lung cancer	0.000169	0.00227	CbGpPWpGaD
Nafcillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000167	0.00225	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	0.000167	0.00224	CbGpPWpGaD
Nafcillin—Feeling abnormal—Doxorubicin—lung cancer	0.000165	0.000468	CcSEcCtD
Nafcillin—Gastrointestinal pain—Doxorubicin—lung cancer	0.000164	0.000465	CcSEcCtD
Nafcillin—Pruritus—Methotrexate—lung cancer	0.000164	0.000464	CcSEcCtD
Nafcillin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000163	0.0022	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTA4—lung cancer	0.000161	0.00217	CbGpPWpGaD
Nafcillin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000161	0.00217	CbGpPWpGaD
Nafcillin—Urticaria—Doxorubicin—lung cancer	0.000159	0.000452	CcSEcCtD
Nafcillin—CYP1A2—Metapathway biotransformation—GSTA4—lung cancer	0.000159	0.00214	CbGpPWpGaD
Nafcillin—Abdominal pain—Doxorubicin—lung cancer	0.000159	0.000449	CcSEcCtD
Nafcillin—Body temperature increased—Doxorubicin—lung cancer	0.000159	0.000449	CcSEcCtD
Nafcillin—Diarrhoea—Methotrexate—lung cancer	0.000159	0.000449	CcSEcCtD
Nafcillin—CYP1A2—Biological oxidations—GSTA2—lung cancer	0.000157	0.00212	CbGpPWpGaD
Nafcillin—SLC22A6—SLC-mediated transmembrane transport—AVP—lung cancer	0.000156	0.0021	CbGpPWpGaD
Nafcillin—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	0.000156	0.0021	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—CYP2A7—lung cancer	0.000153	0.00206	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTA1—lung cancer	0.000152	0.00204	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	0.000151	0.00203	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000151	0.00203	CbGpPWpGaD
Nafcillin—Hypersensitivity—Doxorubicin—lung cancer	0.000148	0.000419	CcSEcCtD
Nafcillin—Vomiting—Methotrexate—lung cancer	0.000147	0.000417	CcSEcCtD
Nafcillin—Rash—Methotrexate—lung cancer	0.000146	0.000414	CcSEcCtD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—lung cancer	0.000146	0.00197	CbGpPWpGaD
Nafcillin—Dermatitis—Methotrexate—lung cancer	0.000146	0.000414	CcSEcCtD
Nafcillin—CYP1A2—Metapathway biotransformation—AKR1C1—lung cancer	0.000143	0.00193	CbGpPWpGaD
Nafcillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000142	0.00191	CbGpPWpGaD
Nafcillin—Pruritus—Doxorubicin—lung cancer	0.000142	0.000402	CcSEcCtD
Nafcillin—CYP1A2—Biological oxidations—UGT1A1—lung cancer	0.000141	0.0019	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—lung cancer	0.00014	0.00188	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—UGT1A1—lung cancer	0.000139	0.00187	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.000139	0.00187	CbGpPWpGaD
Nafcillin—CYP1A2—Phase II conjugation—GSTP1—lung cancer	0.000138	0.00186	CbGpPWpGaD
Nafcillin—Nausea—Methotrexate—lung cancer	0.000138	0.00039	CcSEcCtD
Nafcillin—Diarrhoea—Doxorubicin—lung cancer	0.000137	0.000389	CcSEcCtD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—GNG11—lung cancer	0.000137	0.00184	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTA3—lung cancer	0.000136	0.00183	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	0.000134	0.00181	CbGpPWpGaD
Nafcillin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000132	0.00178	CbGpPWpGaD
Nafcillin—Vomiting—Doxorubicin—lung cancer	0.000128	0.000361	CcSEcCtD
Nafcillin—CYP1A2—Phase II conjugation—GSTM1—lung cancer	0.000127	0.00171	CbGpPWpGaD
Nafcillin—Rash—Doxorubicin—lung cancer	0.000127	0.000358	CcSEcCtD
Nafcillin—Dermatitis—Doxorubicin—lung cancer	0.000126	0.000358	CcSEcCtD
Nafcillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000126	0.00169	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTA4—lung cancer	0.000125	0.00168	CbGpPWpGaD
Nafcillin—CYP1A2—Tryptophan metabolism—MDM2—lung cancer	0.000125	0.00168	CbGpPWpGaD
Nafcillin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000124	0.00167	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—lung cancer	0.000124	0.00167	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	0.000123	0.00165	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000123	0.00165	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000123	0.00165	CbGpPWpGaD
Nafcillin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000122	0.00164	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTA2—lung cancer	0.000121	0.00163	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—lung cancer	0.00012	0.00162	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—HPGDS—lung cancer	0.00012	0.00161	CbGpPWpGaD
Nafcillin—Nausea—Doxorubicin—lung cancer	0.000119	0.000338	CcSEcCtD
Nafcillin—CYP3A4—Biological oxidations—GSTA1—lung cancer	0.000117	0.00158	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTT1—lung cancer	0.000116	0.00157	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GCLC—lung cancer	0.000115	0.00155	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—CYP2A6—lung cancer	0.000115	0.00155	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—TF—lung cancer	0.000114	0.00154	CbGpPWpGaD
Nafcillin—CYP1A2—Arachidonic acid metabolism—PTGS2—lung cancer	0.000112	0.00151	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—lung cancer	0.000111	0.0015	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	0.000111	0.00149	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—UGT1A1—lung cancer	0.000109	0.00147	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—lung cancer	0.000108	0.00146	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	0.000107	0.00145	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000105	0.00142	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—lung cancer	0.000105	0.00141	CbGpPWpGaD
Nafcillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000102	0.00137	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—lung cancer	9.98e-05	0.00134	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—lung cancer	9.98e-05	0.00134	CbGpPWpGaD
Nafcillin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—lung cancer	9.86e-05	0.00133	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—CYP2E1—lung cancer	9.78e-05	0.00132	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—lung cancer	9.71e-05	0.00131	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—lung cancer	9.71e-05	0.00131	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—CYP2E1—lung cancer	9.65e-05	0.0013	CbGpPWpGaD
Nafcillin—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	9.61e-05	0.00129	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—lung cancer	9.46e-05	0.00127	CbGpPWpGaD
Nafcillin—SLC22A6—SLC-mediated transmembrane transport—ALB—lung cancer	9.44e-05	0.00127	CbGpPWpGaD
Nafcillin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	9.39e-05	0.00126	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—lung cancer	9.34e-05	0.00126	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—HPGDS—lung cancer	9.26e-05	0.00125	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTT1—lung cancer	8.98e-05	0.00121	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—CYP2A6—lung cancer	8.88e-05	0.00119	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GCLC—lung cancer	8.88e-05	0.00119	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—lung cancer	8.7e-05	0.00117	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—lung cancer	8.51e-05	0.00115	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—lung cancer	8.51e-05	0.00115	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	8.18e-05	0.0011	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTP1—lung cancer	8.07e-05	0.00109	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—lung cancer	8.04e-05	0.00108	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—GSTP1—lung cancer	7.96e-05	0.00107	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—AVP—lung cancer	7.92e-05	0.00107	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ABCB1—lung cancer	7.67e-05	0.00103	CbGpPWpGaD
Nafcillin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	7.61e-05	0.00102	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—CYP2E1—lung cancer	7.55e-05	0.00102	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	7.45e-05	0.001	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—GSTM1—lung cancer	7.41e-05	0.000998	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—GSTM1—lung cancer	7.31e-05	0.000984	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—CYP1A1—lung cancer	7.03e-05	0.000946	CbGpPWpGaD
Nafcillin—CYP1A2—Metapathway biotransformation—CYP1A1—lung cancer	6.93e-05	0.000933	CbGpPWpGaD
Nafcillin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—lung cancer	6.83e-05	0.000919	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTP1—lung cancer	6.23e-05	0.000838	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—COL4A3BP—lung cancer	6.18e-05	0.000832	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—AZIN2—lung cancer	6.18e-05	0.000832	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	6.14e-05	0.000826	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—APOA1—lung cancer	6.06e-05	0.000815	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	5.76e-05	0.000776	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—GSTM1—lung cancer	5.72e-05	0.00077	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	5.64e-05	0.000759	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	5.58e-05	0.000751	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—CYP1A1—lung cancer	5.42e-05	0.00073	CbGpPWpGaD
Nafcillin—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	5.35e-05	0.00072	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ATP5H—lung cancer	5.26e-05	0.000707	CbGpPWpGaD
Nafcillin—CYP1A2—Biological oxidations—POMC—lung cancer	5.24e-05	0.000705	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—CREBBP—lung cancer	5.13e-05	0.00069	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	4.83e-05	0.00065	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—ALB—lung cancer	4.8e-05	0.000646	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—AZIN2—lung cancer	4.77e-05	0.000642	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—COL4A3BP—lung cancer	4.77e-05	0.000642	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PLBD1—lung cancer	4.69e-05	0.00063	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	4.61e-05	0.00062	CbGpPWpGaD
Nafcillin—SLC22A6—Transmembrane transport of small molecules—RAF1—lung cancer	4.34e-05	0.000584	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—HSD17B10—lung cancer	4.29e-05	0.000577	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ATP5H—lung cancer	4.06e-05	0.000546	CbGpPWpGaD
Nafcillin—CYP3A4—Biological oxidations—POMC—lung cancer	4.04e-05	0.000544	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CKB—lung cancer	3.98e-05	0.000536	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CNDP2—lung cancer	3.75e-05	0.000504	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTM2—lung cancer	3.75e-05	0.000504	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—MTMR3—lung cancer	3.64e-05	0.00049	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PLBD1—lung cancer	3.62e-05	0.000487	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PGAM1—lung cancer	3.55e-05	0.000478	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP2A7—lung cancer	3.39e-05	0.000456	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—SDC4—lung cancer	3.31e-05	0.000446	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—HSD17B10—lung cancer	3.31e-05	0.000445	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CKB—lung cancer	3.07e-05	0.000414	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—RRM1—lung cancer	3.02e-05	0.000406	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTA3—lung cancer	3.02e-05	0.000406	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CNDP2—lung cancer	2.89e-05	0.000389	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTM2—lung cancer	2.89e-05	0.000389	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—B4GALT5—lung cancer	2.84e-05	0.000382	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—MTMR3—lung cancer	2.81e-05	0.000378	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTA4—lung cancer	2.76e-05	0.000372	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PGAM1—lung cancer	2.74e-05	0.000369	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.7e-05	0.000363	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTA2—lung cancer	2.69e-05	0.000362	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP2A7—lung cancer	2.61e-05	0.000352	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTA1—lung cancer	2.6e-05	0.000349	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ABCC3—lung cancer	2.57e-05	0.000345	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—SDC4—lung cancer	2.56e-05	0.000344	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—AKR1C1—lung cancer	2.49e-05	0.000335	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—UGT1A1—lung cancer	2.41e-05	0.000325	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—RRM1—lung cancer	2.33e-05	0.000314	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTA3—lung cancer	2.33e-05	0.000314	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GNG11—lung cancer	2.33e-05	0.000313	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.32e-05	0.000312	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ALDOA—lung cancer	2.22e-05	0.000298	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—B4GALT5—lung cancer	2.19e-05	0.000295	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NCOA3—lung cancer	2.15e-05	0.000289	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTA4—lung cancer	2.13e-05	0.000287	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.11e-05	0.000284	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ADCY1—lung cancer	2.09e-05	0.000282	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ABCG2—lung cancer	2.09e-05	0.000282	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTA2—lung cancer	2.08e-05	0.000279	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—HPGDS—lung cancer	2.05e-05	0.000276	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ENO2—lung cancer	2.05e-05	0.000276	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PPP2R1B—lung cancer	2.04e-05	0.000274	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.01e-05	0.000271	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTA1—lung cancer	2e-05	0.00027	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTT1—lung cancer	1.99e-05	0.000268	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ABCC3—lung cancer	1.98e-05	0.000267	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GCLC—lung cancer	1.97e-05	0.000265	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP2A6—lung cancer	1.97e-05	0.000265	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.96e-05	0.000264	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—AKR1C1—lung cancer	1.92e-05	0.000258	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ENO1—lung cancer	1.87e-05	0.000251	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—UGT1A1—lung cancer	1.86e-05	0.000251	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.86e-05	0.00025	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.83e-05	0.000247	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GNG11—lung cancer	1.8e-05	0.000242	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ALDOA—lung cancer	1.71e-05	0.00023	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP2E1—lung cancer	1.67e-05	0.000225	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NCOA3—lung cancer	1.66e-05	0.000223	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—NQO1—lung cancer	1.65e-05	0.000223	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.62e-05	0.000218	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ABCG2—lung cancer	1.62e-05	0.000217	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ADCY1—lung cancer	1.62e-05	0.000217	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.6e-05	0.000216	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ENO2—lung cancer	1.58e-05	0.000213	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—HPGDS—lung cancer	1.58e-05	0.000213	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.57e-05	0.000212	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTT1—lung cancer	1.54e-05	0.000207	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GCLC—lung cancer	1.52e-05	0.000204	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP2A6—lung cancer	1.52e-05	0.000204	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—STK11—lung cancer	1.49e-05	0.000201	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ENO1—lung cancer	1.44e-05	0.000194	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.4e-05	0.000188	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTP1—lung cancer	1.38e-05	0.000186	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CAT—lung cancer	1.34e-05	0.000181	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.33e-05	0.00018	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ABCB1—lung cancer	1.31e-05	0.000176	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP2E1—lung cancer	1.29e-05	0.000174	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—TYMS—lung cancer	1.28e-05	0.000173	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—NQO1—lung cancer	1.28e-05	0.000172	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—GSTM1—lung cancer	1.27e-05	0.000171	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CYP1A1—lung cancer	1.2e-05	0.000162	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ERCC2—lung cancer	1.19e-05	0.00016	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—STK11—lung cancer	1.15e-05	0.000155	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTP1—lung cancer	1.06e-05	0.000143	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CAT—lung cancer	1.04e-05	0.000139	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—APOA1—lung cancer	1.03e-05	0.000139	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ABCB1—lung cancer	1.01e-05	0.000136	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—TYMS—lung cancer	9.9e-06	0.000133	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.87e-06	0.000133	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—GSTM1—lung cancer	9.78e-06	0.000132	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3CG—lung cancer	9.41e-06	0.000127	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CYP1A1—lung cancer	9.28e-06	0.000125	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ERCC2—lung cancer	9.2e-06	0.000124	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—POMC—lung cancer	8.96e-06	0.000121	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—CREBBP—lung cancer	8.73e-06	0.000117	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3CD—lung cancer	8.28e-06	0.000111	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—ALB—lung cancer	8.17e-06	0.00011	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—APOA1—lung cancer	7.96e-06	0.000107	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3CG—lung cancer	7.27e-06	9.78e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3CB—lung cancer	7.21e-06	9.71e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PTGS2—lung cancer	7.15e-06	9.62e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—POMC—lung cancer	6.92e-06	9.31e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—CREBBP—lung cancer	6.74e-06	9.06e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3CD—lung cancer	6.39e-06	8.59e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—ALB—lung cancer	6.31e-06	8.48e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PTEN—lung cancer	6.23e-06	8.39e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—EP300—lung cancer	5.94e-06	8e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3CB—lung cancer	5.57e-06	7.49e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PTGS2—lung cancer	5.52e-06	7.42e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PTEN—lung cancer	4.81e-06	6.47e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—EP300—lung cancer	4.59e-06	6.17e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—PIK3CA—lung cancer	4.4e-06	5.92e-05	CbGpPWpGaD
Nafcillin—CYP1A2—Metabolism—AKT1—lung cancer	3.59e-06	4.83e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—PIK3CA—lung cancer	3.39e-06	4.57e-05	CbGpPWpGaD
Nafcillin—CYP3A4—Metabolism—AKT1—lung cancer	2.77e-06	3.73e-05	CbGpPWpGaD
